91 . Price J, Turner D and Cepko C. Lineage analysis in the vertebrate nervous system by 
retrovirus-mediated gene transfer. Proc Natl Acad Sci USA, Jan 1987;84(1):1 56-60. 
92. Godbout R, Ingram RS and Tilghman SM. Fine-structure mapping of the three mouse 
alpha-fetoprotein gene enhancers. Mol Cell Biol, Mar 1988;8(3):1 169-78. 
93. Wilson JM, Jefferson DM, Chowdhury JR, Novikoff PM, Johnston DE and Mulligan RC. 
Retrovirus-mediated transduction of adult hepatocytes. Proc Natl Acad Sci USA, May 
1 988;85(9) : 3 0 1 4-8. 
94. Yu SF, von Ruden T, Kantoff PW, Garber C, Seiberg M, Ruther U, Anderson WF, Wagner 
EF and Gilboa E. Self-inactivating retroviral vectors designed for transfer of whole 
genes into mammalian cells. Proc Natl Acad Sci USA, May 1 986;83(1 0):31 94-8. 
95. Goldman L. Cardiac risks and complications of noncardiac surgery. Ann Intern Med, Apr 
1 983;98(4):504-13. 
96. Weitz HH and Goldman L. Noncardiac surgery in the patient with heart disease. Med Clin 
North Am, May 1987;71(3):413-32. 
97. Lim JS, Proudfit WL and Sones FM Jr. Left main coronary arterial obstruction: Long- 
term follow-up of 141 nonsurgical cases. Am J Cardiol, Aug 1 975;36(2):1 31-5. 
98. Bruschke AV, Proudfit WL' and Sones FM Jr. Progress study of 590 consecutive 
nonsurgical cases of coronary disease followed 5-9 years. I. Arterographic correlations. 
Circulation, Jun 1973;47(6):1 147-53. 
99. Kramer JR, Kitazume H, Proudfit WL, Matsuda Y, Williams GW and Sones FM Jr. 
Progression and regression of coronary atherosclerosisirelation to risk factors. Am 
Heart J, Jan 1 983;1 05(1 ):1 34-44. 
100. Killip T, Passamani E and Davis K. Coronary artery surgery study (CASS) : a 
randomized trial of coronary bypass surgery. Eight years follow-up and survival in 
patients with reduced ejection fraction. Circulation, Dec 1985:72(6 Pt 2):V102-9. 
101. Glueck CJ. Role of risk factor management in progression and regression of coronary 
and femoral artery atherosclerosis. Am J Cardiol, May 1986;57(14):35G-41G. 
102. Leffert HL, Koch KS, Moran T and Williams M. Liver cells. Methods Enzymol, 
1979;58:536-44. 
103. Enat R, Jefferson DM, Ruiz-Opazo N, Gatmaitan Z, Leinwald LA and Reid LM. Hepatocyte 
proliferation in vitro: its dependence on the use of serum-free hormonally defined 
medium and substrata of extracellular matrix. Proc Natl Acad Sci USA, 
1984:81 :1411-15. 
104. Korman AJ, Frantz JD, Strominger JL and Mulligan RC. Expression of human class II 
major histocompatibility complex antigens using retrovirus vectors. Proc Natl Acad Sci 
USA, Apr 1 987 ;84(8) :21 50-4. 
105. Van Beveren F, Coffin J and Hughes S. In RNA Tumor Viruses (Weiss R, Teich N, Varmus 
H and Coffin J, eds.) 2nd edit, 1985 , Cold Spring Harbor Lab., Cold Spring Harbor, NY; 
pp. 766-783. 
106. Kost TA, Theodorakis N and Hughes SH. The nucleotide sequence of the chick cytoplasmic 
beta-actin gene. Nucleic Acids Res, Dec 1 983;1 1 (23) :8287-301 . 
107. Seed B and Aruffo A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte 
receptor, by a rapid immunoselection procedure. Proc Natl Acad Sci USA, May 
1987;84(10):3365-9. 
10 8. Boshart M, Weber F, Jahn G, Dorsch-Hasler K, Fleckenstein B and Schaffner W. A very 
strong enhancer is located upstream of an immediate early gene of human 
cytomegalovirus. Cell, Jun 1 985:41 (2):521 -30. 
109. Memsic L, Busuttil RW and Traverso LW. Bleeding esophageal varices and portal vein 
thrombosis after pancreatic mixed-cell autotransplantation. Surgery, 1984;95:238- 
242. 
110. Lawrence TS, Dworzanin LN, Walker-Andrews SC, Andrews JC, TenHaken RK, Wollner 
IS, Lichter AS and Ensminger WD. Treatment of cancers involving the liver and porta 
Recombinant DNA Research, Volume 15 
[ 201 ] 
